

NCT03120533 Raw comparison:

Summary:
CHIA has 27 criteria while your personal folder has 28 criteria
Total found criteria: 21/27
Total not Found: 6/27
Total Extra: 1
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Healthy Volunteers                                 │ Healthy Volunteers                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Age of at least 18 years                           │ Age of at least 18 years                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Existence of a contraceptive method for women of   │ Existence of a contraceptive method for women of   │
│ child-bearing age                                  │ child-bearing age                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Person affiliated to social security or            │ Person affiliated to social security or            │
│ beneficiary of such a scheme                       │ beneficiary of such a scheme                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Signed consent form                                │ Signed consent form                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Systemic sclerosis patients                        │ Systemic sclerosis patients                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Systemic sclerosis meeting the EULAR criteria      │ Systemic sclerosis meeting the EULAR criteria      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Presence of at least 2 ischemic digital cutaneous  │ Presence of 1 ischemic digital cutaneous           │
│ ulcerations on two different fingers with digital  │ ulceration with digital ulcer classified as        │
│ ulcers classified as "active ulcers" according to  │ "active ulcers" according to the North American    │
│ the North American working group definition        │ working group definition epithelial denudation is  │
│ epithelial denudation is clearly Visible at one    │ clearly Visible at one place and the bed of de-    │
│ place and the bed of de-epithelialized ulcer can   │ epithelialized ulcer can be seen Ulcerations       │
│ be seen Ulcerations distal to the proximal         │ distal to the proximal interphalangeal joint not   │
│ interphalangeal joint not associated with          │ associated with calcinosis or bony relief          │
│ calcinosis or bony relief                          │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ulcers whose major axis measured with the          │ Ulcers whose major axis measured with the          │
│ electronic caliper is ≥ 2 mm                       │ electronic caliper is ≥ 2 mm                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Age greater than or equal to 18 years              │ Age greater than or equal to 18 years              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Existence of a contraceptive method for women of   │ Existence of a contraceptive method for women of   │
│ reproductive age                                   │ reproductive age                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ A person who is or is a beneficiary of social      │ A person who is or is a beneficiary of social      │
│ security                                           │ security                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Informed and signed consent signed by the patient  │ Informed and signed consent signed by the patient  │
│ or his / her legal representative                  │ or his / her legal representative                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Treprostinil contraindications Known               │ Treprostinil contraindications Known               │
│ hypersensitivity to treprostinil or any of the     │ hypersensitivity to treprostinil or any of the     │
│ excipients Pulmonary arterial hypertension related │ excipients Pulmonary arterial hypertension related │
│ to veno-occlusive disease Congestive heart failure │ to veno-occlusive disease Congestive heart failure │
│ due to severe left ventricular dysfunction Severe  │ due to severe left ventricular dysfunction Severe  │
│ hepatic insufficiency (Child-Pugh stage C)         │ hepatic insufficiency (Child-Pugh stage C)         │
│ Evolving gastrointestinal ulcer intracranial       │ Evolving gastrointestinal ulcer intracranial       │
│ hemorrhage recent trauma or other clinical         │ hemorrhage recent trauma or other clinical         │
│ condition that may lead to bleeding Congenital or  │ condition that may lead to bleeding Congenital or  │
│ acquired valvular abnormalities with cardiac       │ acquired valvular abnormalities with cardiac       │
│ repercussions Severe ischemic heart disease or     │ repercussions Severe ischemic heart disease or     │
│ unstable angina Myocardial infarction in the last  │ unstable angina Myocardial infarction in the last  │
│ six months Decompensated cardiac insufficiency not │ six months Decompensated cardiac insufficiency not │
│ medically controlled Severe arrhythmias            │ medically controlled Severe arrhythmias            │
│ Cerebrovascular lesions (such as transient         │ Cerebrovascular lesions (such as transient         │
│ ischemic attack stroke) that occurred within the   │ ischemic attack stroke) that occurred within the   │
│ last three months                                  │ last three months                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Persons referred to in Articles L1121-5 to L1121-8 │ Persons referred to in Articles L1121-5 to L1121-8 │
│ of the French Public health Code pregnant woman    │ of the French Public health Code pregnant woman    │
│ parturient nursing mother person deprived of       │ parturient nursing mother person deprived of       │
│ liberty by judicial or administrative decision     │ liberty by judicial or administrative decision     │
│ person subject to a legal protection measure can   │ person subject to a legal protection measure can   │
│ not Be included in clinical trials                 │ not Be included in clinical trials                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject in an exclusion period from another study  │ Subject in an exclusion period from another study  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject who would receive more than 4500 euros of  │ Subject who would receive more than 4500 euros of  │
│ compensation due to his participation in other     │ compensation due to his participation in other     │
│ biomedical research in the 12 months preceding     │ biomedical research in the 12 months preceding     │
│ this study                                         │ this study                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Iloprost cure carried out in the previous month or │ Iloprost cure carried out in the previous month or │
│ planned in the following month                     │ planned in the following month                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Initiation or change of dosage of bosentan         │ Initiation or change of dosage of bosentan         │
│ sildenafil or calcium channel blockers in the      │ sildenafil or calcium channel blockers in the      │
│ previous month or in the following month           │ previous month or in the following month           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Digital Sympathectomy or botulinum toxin injection │ Digital Sympathectomy or botulinum toxin injection │
│ planned in the following month                     │ planned in the following month                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Clinically superinfected digital ulcers            │ Clinically superinfected digital ulcers            │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                                  │
╞══════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Healthy Volunteers                                                                                   │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Systemic sclerosis patients                                                                          │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Treprostinil contraindications Known hypersensitivity to treprostinil or any of the excipients       │
│ Pulmonary arterial hypertension related to veno-occlusive disease Congestive heart failure due to    │
│ severe left ventricular dysfunction Severe hepatic insufficiency (Child-Pugh stage C) Evolving       │
│ gastrointestinal ulcer intracranial hemorrhage recent trauma or other clinical condition that may    │
│ lead to bleeding Congenital or acquired valvular abnormalities with cardiac repercussions Severe     │
│ ischemic heart disease or unstable angina Myocardial infarction in the last six months Decompensated │
│ cardiac insufficiency not medically controlled Severe arrhythmias Cerebrovascular lesions (such as   │
│ transient ischemic attack stroke) that occurred within the last three months                         │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Persons referred to in Articles L1121-5 to L1121-8 of the French Public health Code pregnant woman   │
│ parturient nursing mother person deprived of liberty by judicial or administrative decision person   │
│ subject to a legal protection measure can not Be included in clinical trials                         │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Subject in an exclusion period from another study                                                    │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Subject who would receive more than 4500 euros of compensation due to his participation in other     │
│ biomedical research in the 12 months preceding this study                                            │
╘══════════════════════════════════════════════════════════════════════════════════════════════════════╛



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛